BZ Fine Pharma – Investment Focus

The Fund focuses on mid-sized and smaller specialty pharmaceuticals and bio-pharmaceutical companies. The vast majority of these companies is already on the market with highly innovative products or is close to it. Numerous portfolio companies are also among the market leaders in their field. In addition to in already well-established companies, investments in selected "newcomers" with new therapeutic approaches are being made. Part of the portfolio, for example, is concentrated on undervalued representatives from the nephrology growth area.

BZ Fine Pharma focuses on recognized trends in the healthcare sector in both emerging and developed markets. The investment universe is thus not limited to a specific geographic region.

Investment decisions are based on the fundamental assessment of the companies and not on their market capitalization or their registered office or their headquarters.

A detailed description of the investment policy of the Fund is available in the Sales Prospectus.

Key and general informations